Compound based on 4, 5, 6, 7-tetrahydro-1H-benzimidazole-1-yl methanol core and preparation method and application thereof

By compound based on 4,5,6,7-tetrahydro-1H-benzimidazole-1-ylmethanol, the problem of prone to cracks and peeling of metal anticorrosion coatings is solved, and the metal anticorrosion effect in alkaline environment is achieved , ensure stable pH value and extend the service life of the preservative.

CN119060042AActive Publication Date: 2024-12-03SHANGHAI KESI MICRO SEMICONDUCTOR MATERIALS CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202411126054.2
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-08-15
Publication Date
2024-12-03
Estimated Expiration
2044-08-15

AI Technical Summary

Technical Problem

Existing metal anticorrosion coatings are prone to cracks and peeling, and have poor anticorrosion effect, especially in alkaline environments, it is difficult to prevent metal corrosion, and the reduction in pH value affects the anticorrosion performance.

Method used

Develop a compound based on 4,5,6,7-tetrahydro-1H-benzimidazole-1-ylmethanol and its preparation method, by combining 1-chloromethyl-4,5,6,7-tetrahydrogen -1H-benzimidazole reacts with alkali to produce compounds with anticorrosion properties, which are used for corrosion-proof applications on metal surfaces.

Benefits of technology

This compound can effectively prevent metal corrosion in an alkaline environment, and the pH value of the test solution does not significantly reduce, extend the service life of the preservative and improve the anticorrosion ability of the metal.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119060042A_ABST
    Figure CN119060042A_ABST
Patent Text Reader

Abstract

The invention discloses a compound based on a 4, 5, 6, 7-tetrahydro-1H-benzimidazole-1-yl methanol core as well as a preparation method and application of the compound. The compound has a structure as shown in a formula I: # imgabs0 #. According to the invention, the 4, 5, 6, 7-tetrahydro-1H-benzimidazole-1-yl methanol core is structurally modified by selecting a proper chemical reagent, so that the compound has a good application prospect in the field of chemical synthesis. Therefore, compounds with different corrosion resistance can be obtained, and different application requirements can be met. The compound disclosed by the invention can prevent metal from being corroded in an alkaline environment, and the pH value of a test solution is not obviously reduced.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of metal corrosion protection, and specifically relates to a compound based on a 4,5,6,7-tetrahydro-1H-benzimidazole-1-ylmethanol core, and a preparation method and application thereof. Background Art

[0002] Metal corrosion is a phenomenon in which metals are destroyed by chemical or electrochemical effects of the environment. Metal corrosion affects all areas of marginal industrial production, causing huge economic losses, leading to an increase in the use of metal materials, and is not conducive to energy conservation, emission reduction and environmental protection.

[0003] Metal corrosion mainly includes two forms: electrochemical corrosion and seawater corrosion. Electrochemical corrosion is the damage caused by electrochemical reaction between the metal surface and the ion-conductive medium. Its main feature is that its reaction process can be divided into two relatively independent and simultaneous processes-cathode reaction and anode reaction. Its main feature is that there is a charged interface layer between the metal and the electrolyte. Seawater corrosion refers to the corrosion of equipment and facilities used in the marine environment. Seawater has the highest salt content and complex composition, and is a corrosive electrolyte. The high concentration of chloride ions and other halogen ions in seawater can prevent and destroy the passivation of metals, making the anode process easier to carry out. Under the pH value of seawater, seawater corrosion is an oxygen depolarization process, and the cathode process controls the speed of the corrosion reaction.

[0004] For a long time, people have been using a variety of technologies to protect metals. One of the most effective and economical methods is to apply an anti-corrosion coating on the metal surface to isolate the corrosive medium from the metal substrate. However, during the use of the coating, microcracks will occur due to changes in factors such as the environment or mechanical properties, and due to exposure to the atmosphere, the microcracks will gradually spread and expand, thereby accelerating the peeling and stratification of the coating at the interface between the metal and the coating, reducing the service life and anti-corrosion ability of the coating, and also affecting the use of the metal. Therefore, a metal preservative is needed to prevent the corrosion of metal materials and solve the problems of metal anti-corrosion coatings in the prior art that are prone to cracking, peeling, and poor anti-corrosion effects. Summary of the invention

[0005] In order to improve the above technical problems, the present invention provides a compound based on 4,5,6,7-tetrahydro-1H-benzimidazol-1-ylmethanol as a core, and a preparation method and application thereof. The compound of the present invention can prevent metal corrosion in an alkaline environment and the pH value of the test liquid does not decrease significantly.

[0006] In order to achieve the above object, the present invention provides a compound with a structure shown in Formula I:

[0007]

[0008] Wherein, R is selected from saccharinyl, -O-CO-C 1-6 Alkyl, furanoyl.

[0009] According to an embodiment of the present invention, the compound of the structure shown in Formula I is selected from the following compounds:

[0010]

[0011] The present invention also provides a method for preparing the compound of the structure shown in the above formula I, its stereoisomers or pharmaceutically acceptable salts and hydrates thereof, comprising reacting 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole with compound RH to obtain a compound of formula I; wherein: R has the definition and selection as described above.

[0012] According to an embodiment of the present invention, the molar ratio of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to compound RH is (1-5):1, exemplified by 1:1, 1.1:1, 1.5:1, 2:1, 5:1.

[0013] According to an embodiment of the present invention, in the reaction of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole with compound RH, a base is preferably added.

[0014] Preferably, the molar ratio of the 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to the base is 1:(1-5), exemplified by 1:1, 1:2.2, and 1:5.

[0015] Preferably, the base is selected from one, two or more of N,N-diisopropylethylamine (DIPEA), potassium carbonate, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate and sodium acetate.

[0016] According to an embodiment of the present invention, NaI is preferably added in the reaction of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole with compound RH.

[0017] Preferably, the molar ratio of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to NaI is (1-5):1, exemplified by 1:1, 1.1:1, 1.5:1, 2:1, and 5:1.

[0018] According to an embodiment of the present invention, the method for preparing the compound of the structure shown in Formula I can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from 1,2-dichloroethane and tetrahydrofuran.

[0019] According to an embodiment of the present invention, the reaction temperature is 40-100°C, exemplified by 40°C, 60°C, 80°C, and 100°C; the reaction time is 1-48h, exemplified by 1h, 2h, 4h, 6h, 8h, 12h, 16h, 24h, 36h, and 48h.

[0020] According to an embodiment of the present invention, the preparation method further comprises a step of separating a solid product from the reaction mixture after the reaction is completed. For example, a solid product is obtained by spin drying the solvent. Further, the preparation method further comprises a step of purifying the product. For example, the purification can be separated by column chromatography. Preferably, the eluent separated by the column chromatography is ethyl acetate / methanol=(1-500):1(v / v), exemplified by 1:1, 100:1, 500:1.

[0021] Preferably, the synthetic route of the compound of formula I is as follows:

[0022]

[0023] According to an embodiment of the present invention, the method for preparing the compound having the structure shown in Formula I comprises the following steps:

[0024] (1) Under nitrogen protection, a nucleophilic reagent RH, 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole, sodium iodide, a base and a solvent are stirred for reaction;

[0025] (2) After the reaction is completed, cool to room temperature and concentrate to remove the solvent;

[0026] (3) The crude product is purified by silica gel column chromatography using a mixed solvent of ethyl acetate and methanol as the eluent to obtain a compound with the structure shown in Formula I.

[0027] According to an embodiment of the present invention, the 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole is prepared by a nucleophilic substitution reaction of (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol and a chlorinating agent.

[0028] In one embodiment of the present invention, the molar ratio of (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol to the chlorinating agent is 1:(1-10), exemplified by 1:1, 1:6, and 1:10.

[0029] In one embodiment of the present invention, the chlorinating agent is, for example, selected from thionyl chloride, phosphorus trichloride or phosphorus oxychloride.

[0030] In one embodiment of the present invention, the preparation method of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from chloroform.

[0031] According to an embodiment of the present invention, the reaction temperature is room temperature; the reaction time is 1 to 48 hours, exemplified by 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 16 hours, 24 hours, 36 hours, and 48 hours.

[0032] According to an embodiment of the present invention, the preparation method further comprises the step of separating a solid product from the reaction mixture after the reaction is completed. For example, the solid product is obtained by spin drying the solvent.

[0033] According to an embodiment of the present invention, the (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol is prepared by reacting 4,5,6,7-tetrahydro-1H-benzimidazole with formaldehyde.

[0034] In one embodiment of the present invention, the molar ratio of 4,5,6,7-tetrahydro-1H-benzimidazole to formaldehyde is 1:(0.5-2), exemplified by 1:0.5, 1:1, and 1:2.

[0035] In one embodiment of the present invention, the preparation method of (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from tetrahydrofuran.

[0036] In one embodiment of the present invention, the reaction temperature is room temperature; the reaction time is 1 to 48 hours, exemplified by 1 hour, 2 hours, 4 hours, 6 hours, 8 hours, 12 hours, 16 hours, 24 hours, 36 hours, and 48 hours.

[0037] In one embodiment of the present invention, the preparation method further comprises the step of separating a solid product from the reaction mixture after the reaction is completed, for example, by spin drying the solvent to obtain the solid product.

[0038] In one embodiment of the present invention, the synthetic route of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole is as follows:

[0039]

[0040] The present invention also provides the use of the compound with the structure shown in the above formula I in the cleaning and corrosion protection of the surface of metal products.

[0041] The present invention also provides a detergent containing the compound with the structure shown in the above formula I.

[0042] The present invention also provides a preservative, which contains the compound with the structure shown in the above formula I.

[0043] According to an embodiment of the present invention, the preservative further comprises an auxiliary agent. Preferably, the auxiliary agent is selected from a sustained-release agent and / or a surfactant.

[0044] In one embodiment of the present invention, the sustained release agent is selected from triethanolamine borate.

[0045] In one embodiment of the present invention, the surfactant is 2-amino-2-methyl-propanol.

[0046] According to an embodiment of the present invention, the preservative further contains tetramethylammonium hydroxide.

[0047] According to an embodiment of the present invention, in the preservative, the mass of the compound of the structure shown in Formula I is 0.01% to 20% of the mass of tetramethylammonium hydroxide, and exemplified are 0.01%, 0.04%, 0.1%, 0.5%, 1%, 2%, 5%, 10%, 15%, and 20%.

[0048] The present invention also provides an anti-corrosion coating, which contains the compound with the structure shown in the above formula I and / or is prepared from the compound with the structure shown in the above formula I.

[0049] Definition and explanation of terms

[0050] Unless otherwise specified, the definitions of groups and terms recorded in the specification and claims of this application, including their definitions as examples, exemplary definitions, preferred definitions, definitions recorded in tables, definitions of specific compounds in examples, etc., can be arbitrarily combined and combined with each other. The group definitions and compound structures after such combinations and combinations shall fall within the scope of the description of this application.

[0051] Unless otherwise specified, the numerical ranges described in this specification and claims are equivalent to at least describing each specific integer value therein. For example, the numerical range "1-6" is equivalent to describing each integer value in the numerical range "1-6", namely 1, 2, 3, 4, 5, 6. It should be understood that when used herein to describe a substituent, "multiple" refers to an integer ≥ 2, such as 2, 3, 4, 5, 6, 7, 8, 9 or 10.

[0052] The term "C 1-6The term "alkyl" refers to a straight-chain or branched saturated hydrocarbon group having 1, 2, 3, 4, 5 or 6 carbon atoms. The alkyl group is, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, 2-methylbutyl, 1-methylbutyl, 1-ethylpropyl, 1,2-dimethylpropyl, neopentyl, 1,1-dimethylpropyl, 4-methylpentyl, 3-methylpentyl, 2-methylpentyl, 1-methylpentyl, 2-ethylbutyl, 1-ethylbutyl, 3,3-dimethylbutyl, 2,2-dimethylbutyl, 1,1-dimethylbutyl, 2,3-dimethylbutyl, 1,3-dimethylbutyl or 1,2-dimethylbutyl or the like or isomers thereof.

[0053] The term "C 3-6 "Cycloalkyl" is understood to mean a saturated monocyclic alkane having 3, 4, 5 or 6 carbon atoms. For example, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl.

[0054] The term "heterocyclyl" is understood to mean a saturated or partially unsaturated monocyclic or bicyclic non-aromatic cyclic group with a total ring number of 3-20 (such as 3, 4, 5, 6, 7, 8, 9, 10, etc.) containing 1-5 heteroatoms independently selected from N, O and S, preferably a "3-10 membered heterocyclyl". The term "3-10 membered heterocyclyl" means a saturated or partially unsaturated monocyclic or bicyclic hydrocarbon ring, and contains 1-5, preferably 1-3 heteroatoms independently selected from N, O and S, such as 1, 2, 3 heteroatoms independently selected from N, O and S. The heterocyclyl may be attached to the rest of the molecule via any of the carbon atoms or the nitrogen atom (if present). In particular, the heterocyclic group may include, but is not limited to, a 4-membered ring such as azetidinyl, oxetanyl; a 5-membered ring such as furanyl, tetrahydrofuranyl, dioxolyl, pyrrolidinyl, imidazolidinyl, pyrazolidinyl, pyrrolinyl; or a 6-membered ring such as tetrahydropyranyl, piperidinyl, morpholinyl, dithianyl, thiomorpholinyl, tetrahydropyridinyl, 2H-pyranyl, piperazinyl or trithianyl; or a 7-membered ring such as diazepanyl. Optionally, the heterocyclic group may be benzo-fused. The ring containing the nitrogen atom may be partially unsaturated, i.e., it may contain one or more double bonds, such as, but not limited to, 2,5-dihydro-1H-pyrrolyl, 4H-[1,3,4]thiadiazinyl, 4,5-dihydrooxazolyl or 4H-[1,4]thiazinyl, or it may be benzo-fused, such as, but not limited to, dihydroisoquinolinyl. The heterocyclic group may be a spiro ring.

[0055] Beneficial effects of the present invention:

[0056] The present invention discloses a compound based on 4,5,6,7-tetrahydro-1H-benzimidazol-1-ylmethanol as a core, a preparation method and an application thereof. The present invention selects a suitable chemical reagent to structurally modify the 4,5,6,7-tetrahydro-1H-benzimidazol-1-ylmethanol core to obtain compounds with different anticorrosion properties, thereby meeting different application requirements. The compound of the present invention can prevent metal from being corroded in an alkaline environment and the pH value of the test solution does not decrease significantly. BRIEF DESCRIPTION OF THE DRAWINGS

[0057] Figure 1 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide prepared in Example 1 1 H NMR spectrum.

[0058] Figure 2 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide prepared in Example 1 13 C NMR spectrum. DETAILED DESCRIPTION

[0059] The technical scheme of the present invention will be further described in detail below in conjunction with specific embodiments. It should be understood that the following embodiments are only exemplary descriptions and explanations of the present invention and should not be construed as limiting the scope of protection of the present invention. All technologies implemented based on the above content of the present invention are included in the scope that the present invention is intended to protect.

[0060] Unless otherwise specified, the raw materials and reagents used in the following examples are commercially available or can be prepared by known methods.

[0061] Example 1

[0062] This embodiment provides a method for preparing 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide, and the reaction equation is:

[0063]

[0064] A method for preparing 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide comprises the following steps:

[0065] (1) Under nitrogen protection, benzo[d]isothiazol-3(2H)-one 1,1-dioxide (1.8 g, 10.0 mmol), 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole (2.3 g, 11.0 mmol), sodium iodide (1.5 g, 10.0 mmol) and N,N-diisopropylethylamine (2.8 g, 22.0 mmol) and tetrahydrofuran (40.0 mL) were added to a 250.0 mL reaction bottle in sequence and reacted at room temperature of 60°C for 16 h;

[0066] (2) After stirring for 16 h, the mixture was cooled to room temperature and concentrated on a rotary evaporator at 40 °C without any post-treatment;

[0067] (3) The crude product was purified by silica gel column chromatography using a mixed solvent of ethyl acetate and methanol in a volume ratio of 100:1 as the eluent to obtain a white solid (yield 50%), namely 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide, with the structural formula:

[0068] Among them, the preparation method of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole has the following reaction equation:

[0069]

[0070] The preparation method of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole comprises the following steps:

[0071] (1) 4,5,6,7-tetrahydro-1H-benzimidazole (1.2 g, 10.0 mmol) and tetrahydrofuran (30.0 mL) were added sequentially to a 150.0 mL reaction bottle, followed by dropwise addition of formaldehyde aqueous solution (concentration 37%, 0.8 g, 10.0 mmol), and the mixture was stirred at room temperature for 12 h;

[0072] (2) After stirring for 12 h, without any post-treatment, the components were concentrated on a rotary evaporator at 40° C. to obtain a crude product (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol, the structural formula of which is: (The crude product was not treated and directly carried to the next step);

[0073] (3) In a 200.0 mL reaction bottle, (4,5,6,7-tetrahydrobenzo[d]imidazol-1-yl)methanol (1.5 g, 10.0 mmol) and chloroform (50.0 mL) were added in sequence, followed by dropwise addition of thionyl chloride (7.1 g, 60.0 mmol), and the reaction was stirred at room temperature for 6 h;

[0074] (4) After stirring for 6 h, the components were concentrated on a rotary evaporator at 40° C. without any post-treatment to directly obtain the desired white solid (yield 85%), namely 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole, whose structural formula is:

[0075] The characterization results of 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide prepared in this example are as follows:

[0076] 1 H NMR (400MHz, CDCl3) δ8.09-8.06 (m, J=7.4, 1.0Hz, 1H), 7.95–7.82 (m, 3H), 7.70 (s,1H),5.69(s,2H),2.73-2.69(m,2H),2.57-2.54(m,2H),1.91-1.70(m,4H)( Figure 1 ).

[0077] 13 C NMR (101MHz, CDCl3) δ158.66,137.44,137.15,136.65,135.70,134.89,126.53,125.80,121.38,45.79,24.24,23.13,22.96,20.34( Figure 2 ).

[0078] The method is basically the same as the above preparation method, except that when potassium carbonate is used instead of DIPEA, no target product of 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide is generated.

[0079] Test Example 1

[0080] Add 10.0g of DEV base (2.38% tetramethylammonium hydroxide aqueous solution) to a 20.0mL conical flask, add a magnet, turn on electromagnetic stirring to mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (3 hours in total), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 1 below.

[0081] Table 1

[0082]

[0083] Test Example 2

[0084] Add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), and 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant) to a 20.0mL conical flask, add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (a total of 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 2 below.

[0085] Table 2

[0086]

[0087] Test Example 3

[0088] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.15g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.2g (completely dissolved) of 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide prepared in Example 1, add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (total 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 25-27°C. The measurement results are shown in Table 3 below.

[0089] Table 3

[0090]

[0091] Test Example 4

[0092] In a 20.0mL conical flask, add 10.0g of DEV base (aqueous solution of tetramethylammonium hydroxide with a concentration of 2.38%), 0.2g of additive 1 (triethanolamine borate sustained-release agent), 0.01g of additive 2 (2-amino-2-methyl-propanol surfactant), 0.15g (completely dissolved) of 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide prepared in Example 1, add a magnet, turn on electromagnetic stirring, mix the solution evenly, and set the water bath temperature to 25-27°C. Then cut the aluminum sheet into 1cm*1cm small squares and put them in the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh it. Then put it in the solution again, soak for another 2 hours (total 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 18°C. The measurement results are shown in Table 4 below.

[0093] Table 4

[0094]

[0095]

[0096] Test Example 5

[0097] Take 10.0 g of each of the reference solutions I, II, III, and IV in Table 5 and add them to four conical flasks, then add 20.0 mg of 2-((4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)methyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide (completely dissolved) prepared in Example 1, and measure the pH value of the solution at 25-27°C after dissolution; then cut the aluminum sheet into 1cm*1cm small squares and put them into the conical flask. After soaking for 1 hour, take it out with tweezers, rinse both sides with distilled water several times, wipe dry and weigh; measure the pH value of the solution at 25-27°C. Then put it into the solution again, soak for another 2 hours (total 3 hours), weigh the weight after corrosion, and then measure the pH value of the solution at 25-27°C. The measurement results are shown in Tables 6 and 7 below.

[0098] Table 5

[0099] Reference fluid Ⅰ DEV base 50 g Additive 1 0.75 g Additive 2 0.05 g Reference Fluid Ⅱ DEV base 50 g Additive 1 1.0g Additive 2 0.05 g Reference fluid Ⅲ DEV base 50 g - Additive 2 0.05 g Reference fluid IV DEV base 50 g - -

[0100] Note: “-” in the table means no addition; DEV base is a 2.38% tetramethylammonium hydroxide aqueous solution, additive 1 is a triethanolamine borate sustained-release agent, and additive 2 is a 2-amino-2-methyl-propanol surfactant.

[0101] Table 6

[0102]

[0103] Note: Condition Ⅰ, Condition ⅠⅠ, Condition ⅠⅠⅠ, and Condition ⅣV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ, reference solution ⅠⅠⅠ, and reference solution ⅣV respectively.

[0104] Table 7

[0105]

[0106] Note: Condition Ⅰ, Condition ⅠⅠ, Condition ⅠⅠⅠ, and Condition ⅣV in the table correspond to the above-mentioned reference solution Ⅰ, reference solution ⅠⅠ, reference solution ⅠⅠⅠ, and reference solution ⅣV respectively.

[0107] The above is an explanation of the embodiments of the present invention. However, the present invention is not limited to the above embodiments. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present invention shall be included in the protection scope of the present invention.

Claims

1. A compound having a structure shown in formula I: in, R is selected from saccharinyl, -O-CO-C 1-6 Alkyl, furanoyl.

2. The compound of the structure shown in formula I as claimed in claim 1, characterized in that It is selected from the following compounds:

3. A method for preparing the compound of formula I, its stereoisomer or its pharmaceutically acceptable salt or hydrate according to claim 1, characterized in that: The preparation method comprises reacting 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole with compound RH to obtain a compound of formula I; wherein: R has the definition and selection as described above.

4. The preparation method according to claim 3, characterized in that: The molar ratio of the 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to the compound RH is (1-5):1; Preferably, in the reaction of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole with compound RH, a base is preferably added; Preferably, the molar ratio of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to the base is 1:(1-5); Preferably, the base is selected from one, two or more of N,N-diisopropylethylamine (DIPEA), potassium carbonate, sodium tert-butoxide, potassium tert-butoxide, potassium phosphate, and sodium acetate; Preferably, in the reaction of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole and compound RH, NaI is preferably added; Preferably, the molar ratio of 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole to NaI is (1-5):1; Preferably, the method for preparing the compound of the structure represented by Formula I can be carried out in the presence of a solvent such as an organic solvent. For example, the organic solvent can be selected from 1,2-dichloroethane and tetrahydrofuran; Preferably, the reaction temperature is 40 to 100° C.; the reaction time is 1 to 48 hours; Preferably, the preparation method further comprises the step of separating a solid product from the reaction mixture after the reaction is completed, for example, by spin-drying the solvent to obtain a solid product; Preferably, the preparation method further comprises the step of purifying the product, for example, the purification can be carried out by column chromatography separation; preferably, the eluent for column chromatography separation is ethyl acetate / methanol = (1-500): 1 (v / v).

5. The preparation method according to claim 3 or 4, characterized in that: The method for preparing the compound with the structure shown in Formula I comprises the following steps: (1) Under nitrogen protection, a nucleophilic reagent RH, 1-chloromethyl-4,5,6,7-tetrahydro-1H-benzimidazole, sodium iodide, a base and a solvent are stirred for reaction; (2) After the reaction is completed, cool to room temperature and concentrate to remove the solvent; (3) The crude product is purified by silica gel column chromatography using a mixed solvent of ethyl acetate and methanol as the eluent to obtain a compound with the structure shown in Formula I.

6. Use of the compound of formula I according to claim 1 or 2 in cleaning and anti-corrosion of metal product surfaces.

7. A detergent, characterized in that It contains the compound with the structure shown in formula I according to claim 1 or 2.

8. A preservative, characterized in that It contains the compound with the structure shown in formula I according to claim 1 or 2.

9. The preservative according to claim 8, characterized in that The preservative also contains an auxiliary agent; Preferably, the auxiliary agent is selected from a sustained-release agent and / or a surfactant; Preferably, the sustained-release agent is selected from triethanolamine borate; Preferably, the surfactant is 2-amino-2-methyl-propanol; Preferably, the preservative further comprises tetramethylammonium hydroxide; Preferably, in the preservative, the mass of the compound having the structure shown in Formula I is 0.01 to 20% of the mass of tetramethylammonium hydroxide.

10. An anti-corrosion coating, characterized in that: It contains the compound with the structure shown in formula I according to claim 1 or 2 and / or is prepared from the compound with the structure shown in formula I according to claim 1 or 2.

Citation Information

Patent Citations

  • Aqueous formulations for removing metal hard mask and post-etch residue with Cu / W compatibility

    CN105431506A

  • Molecule based on saccharin derivative and preparation method and application thereof

    CN114409645A

  • 4,5,6,7-tetrahydrobenzimidazoles, process for their production and their use as corrosion inhibitors and antioxidants

    GB1260294A

  • 4,5,6,7-tetrahydrobenzimidazoles

    GB1310998A

  • 4,5,6,7-Tetrahydrobenzimidazoles

    US3987054A